Tetrahydroisoquinolinone-based steroidomimetic and chimeric microtubule disruptors

Mathew P. Leese, Fabrice L. Jourdan, M.R. Major, Wolfgang Dohle, Ernest Hamel, Eric Ferrandis, Ann Fiore, Philip G. Kasprzyk, Barry V. L. Potter

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Abstract

A structure-activity relationship (SAR) translation strategy was used for the discovery of tetrahydroisoquinoline (THIQ)-based steroidomimetic and chimeric microtubule disruptors based upon a steroidal starting point. A steroid A,B-ring-mimicking THIQ core was connected to methoxyaryl D-ring ring mimics through methylene, carbonyl and sulfonyl linkers to afford a number of steroidomimetic hits (e.g., 7-methoxy-2-(3- methoxybenzyl)-6-sulfamoyloxy-1,2,3,4-tetrahydroisoquinoline (20c) GI=2.1μM). Optimisation and control experiments demonstrate the complementary SAR of this series and the steroid derivatives that inspired its design. Linkage of the THIQ-based A,B-mimic with the trimethoxyaryl motif prevalent in colchicine site binding microtubule disruptors delivered a series of chimeric molecules whose activity (GI=40nM) surpasses that of the parent steroid derivatives. Validation of this strategy was obtained from the excellent oral activity of 7-methoxy-6-sulfamoyloxy-2-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline (20z) relative to a benchmark steroidal bis- sulfamate in an in vivo model of multiple myeloma.
Original languageEnglish
Pages (from-to)85-108
Number of pages24
JournalChemMedChem
Volume9
Issue number1
Early online date9 Oct 2013
DOIs
Publication statusPublished - Jan 2014

Fingerprint Dive into the research topics of 'Tetrahydroisoquinolinone-based steroidomimetic and chimeric microtubule disruptors'. Together they form a unique fingerprint.

Cite this